Giant Cell Tumor of Bone Without Giant Cells with a Long Clinical Course: A Case Report.
H3.3 G34W
bone formation
denosumab
giant cell tumor of bone
immunohistochemistry
Journal
International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
pubmed:
4
5
2022
medline:
16
3
2023
entrez:
3
5
2022
Statut:
ppublish
Résumé
Giant cell tumor of bone (GCTB) consists of a mixture of neoplastic mononuclear cells and non-neoplastic cells, including polynuclear giant cells. Recently, with the spread of the immunohistochemical staining marker H3.3 G34W corresponding to specific genetic abnormalities, the histological diversity of GCTB has been recognized. GCTB without giant cells is uncommon, although it has also been reported previously. Herein, we describe a 45-year-old man with GCTB without giant cells who was successfully diagnosed using H3.3 G34W immunohistochemistry. Other unusual findings in GCTB that were identified in this patient include bone and osteoid formation with a long clinical course of 13 years. We also compared the histological findings of the current patient to those who received denosumab therapy.
Identifiants
pubmed: 35502834
doi: 10.1177/10668969221098090
doi:
Substances chimiques
Histones
0
Denosumab
4EQZ6YO2HI
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM